Iris Diseases: Clinical Trials

4 trials for Iris Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 enrolling by invitation. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Enrolling by invitation 1
Phase 22Completed 1, Enrolling by invitation 1

Follow Iris Diseases: new trials by email Literature Review of Iris Diseases trials Research Report on Iris Diseases

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Insulin for Glaucoma (TING2)
EYED-002 Low Dose (721 U/mL topical insulin), EYED-002 High Dose (1442 U/mL topical insulin), EYED-002 (highest tolerated dose, 12-month) - Open Angle Glaucoma, Primary Open Angle Glaucoma
Phase 1 / Phase 2Enrolling by invitationStanford University902026-09-102026-10-13
Treatment of LSCD With DM
transplantation of a Descemet's Membrane corneal onlay, partial LSCD, transplantation of a Descemet's Membrane corneal onlay, total/near-total LSCD - Limbal Stem-cell Deficiency, Congenital Aniridia
Phase 1CompletedUniversity of Minnesota192023-11-302026-01-08
RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy
RAFT-OS - Aniridia
Phase 1 / Phase 2CompletedUniversity College, London92021-07-282025-04-30
The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis
Chicken type II collagen - Arthritis, Juvenile Rheumatoid, Uveitis
Phase 1CompletedNational Eye Institute (NEI)131997-07-012008-03-04

Narrower conditions

Aniridia (2)  ·  Arthritis, Juvenile (1)  ·  Exfoliation Syndrome (1)  ·  Glaucoma (1)  ·  Glaucoma, Open-Angle (1)  ·  Inflammation (1)  ·  Iritis (1)  ·  Limbal Stem Cell Deficiency (1)  ·  Low Tension Glaucoma (1)  ·  Uveitis (1)

Broader conditions

Eye Diseases (4)  ·  Uveal Diseases (4)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Eye Abnormalities (2)  ·  Eye Diseases, Hereditary (2)  ·  Genetic Diseases, Inborn (2)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Corneal Diseases (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)

Interventions

Insulin (1)

Sponsors

National Eye Institute (NEI) (1)  ·  Stanford University (1)  ·  University College, London (1)  ·  University of Minnesota (1)

Countries

United States (3)  ·  United Kingdom (1)

Top investigators

Jeffrey L Goldberg, MD PhD (1)  ·  Julie Daniels (1)  ·  Sajjad Ahmad (1)  ·  Stephen Kaufman, MD (1)

Results publications

PMID 42490097